Novartis Investigative Site

Paris, Cedex 10 75475

0 studies enrolling now · 5 studies all time

What they study most

B-cell Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Moderate to Severe Plaque-type Psoriasis, Myelogenous Leukemia, Chronic, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia, Transplant Associated Microangiopathy TAM

Studies at this site

• A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL — Completed
• Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients — Completed
• Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients — Stopped early
• A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) — Completed
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab — Completed